CHU de Besancon, Hopital Jean Minjoz

Besançon 25030

0 studies enrolling now · 8 studies all time

What they study most

Advanced Cancer, Biliary Tract Cancer, Blastic Plasmacytoid Dendritic Cell Neoplasm, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Hepatocellular Carcinoma, Hepatocellular Carcinoma Surveillance, Metastatic Cancer, Multiple Sclerosis, Myeloproliferative Neoplasm, Pancreatic Cancer

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) — Running, not enrolling
• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer — Running, not enrolling
• Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN — Running, not enrolling
• Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer — Completed
• Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
• A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer — Withdrawn before enrolling